Home Ricerca Sedi Chi siamo Organigramma Personale Contatti Didattica Login Documenti EN
Progetti in evidenza
INCIPIT
(Link esterno)

ISTAPCA
(1206 visite)

Fondo Europeo Pesca
(618 visite)

Euro-BioImaging
(Link esterno)

Fondazione Veronesi
(Link esterno)

LightDyNAmics
(1089 visite)

 INMiND
(1183 visite)

Instruct-IT
(Link esterno)

 PRIN
(1326 visite)

 eHealthNet
(1087 visite)

Ponrec
(1026 visite)

MFAG Grant
(1131 visite)

MERIT
(Link esterno)


Collegamenti

Contiene: [X]      Estesa     Autori: [X]  Tipo di lavoro: [X]
Data iniziale: Data finale: [X]      Sede: Affiliazione IBB     
    
[Pulisci modulo]



APEH Inhibition Affects Osteosarcoma Cell Viability via Downregulation of the Proteasome (91 visite)

Palumbo R, Gogliettino M, Cocca E, Iannitti R, Sandomenico A, Ruvo M, Balestrieri M, Rossi M, Palmieri G

Int J Mol Sc (ISSN: 1422-0067electronic, 1422-0067linking, 1661-6596), 2016 Sep 23; 17(10): N/D-N/D.

Tipo di articolo: Journal Article, , Impact factor: 3.226, Impact factor a 5 anni: 3.482, Url: Non disponibile.

Parole chiave: Acylpeptide Hydrolase (apeh), Anti-Tumoral Target, Osteosarcoma Cell Lines, Peptide Inhibitor, Proteasome,

Affiliazioni: *** IBB - CNR ***
Institute of Biostructure and Bioimaging, National Research Council (CNR-IBB), Napoli 80134, Italy. rosanna.palumbo@cnr.it., Institute of Biosciences and BioResources, National Research Council (CNR-IBBR), Napoli 80131, Italy. marta.gogliettino@ibbr.cnr.it., Institute of Biosciences and BioResources, National Research Council (CNR-IBBR), Napoli 80131, Italy. ennio.cocca@ibbr.cnr.it., Institute of Biostructure and Bioimaging, National Research Council (CNR-IBB), Napoli 80134, Italy. robertaiannitti@gmail.com., Institute of Biostructure and Bioimaging, National Research Council (CNR-IBB), Napoli 80134, Italy. annamaria.sandomenico@gmail.com., Institute of Biostructure and Bioimaging, National Research Council (CNR-IBB), Napoli 80134, Italy. menotti.ruvo@unina.it., Institute of Biosciences and BioResources, National Research Council (CNR-IBBR), Napoli 80131, Italy. marco.balestrieri@ibbr.cnr.it., Institute of Biosciences and BioResources, National Research Council (CNR-IBBR), Napoli 80131, Italy. mose.rossi@ibbr.cnr.it., Institute of Biosciences and BioResources, National Research Council (CNR-IBBR), Napoli 80131, Italy. gianna.palmieri@ibbr.cnr.it.,


Riferimenti: Non disponibile.

The proteasome is a multienzymatic complex that controls the half-life of the majority of intracellular proteins, including those involved in apoptosis and cell-cycle progression. Recently, proteasome inhibition has been shown to be an effective anticancer strategy, although its downregulation is often accompanied by severe undesired side effects. We previously reported that the inhibition of acylpeptide hydrolase (APEH) by the peptide SsCEI 4 can significantly affect the proteasome activity in A375 melanoma or Caco-2 adenocarcinoma cell lines, thus shedding new light on therapeutic strategies based on downstream regulation of proteasome functions. In this work, we investigated the functional correlation between APEH and proteasome in a panel of cancer cell lines, and evaluated the cell proliferation upon SsCEI 4-treatments. Results revealed that SsCEI 4 triggered a proliferative arrest specifically in osteosarcoma U2OS cells via downregulation of the APEH-proteasome system, with the accumulation of the typical hallmarks of proteasome: NF-kappaB, p21(Waf1), and polyubiquitinylated proteins. We found that the SsCEI 4 anti-proliferative effect involved a senescence-like growth arrest without noticeable cytotoxicity. These findings represent an important step toward understanding the mechanism(s) underlying the APEH-mediated downregulation of proteasome in order to design new molecules able to efficiently regulate the proteasome system for alternative therapeutic strategies.

Contiene: [X]      Estesa     Autori: [X]  Tipo di lavoro: [X]
Data iniziale: Data finale: [X]      Sede: Affiliazione IBB     
    
[Pulisci modulo]


Sbardella D, Tundo GR, Coletta A, Marcoux J, Koufogeorgou EI, Ciaccio C, Santoro AM, Milardi D, Grasso G, Cozza P, Bousquet-dubouch MP, Marini S, Coletta M
* The insulin-degrading enzyme is an allosteric modulator of the 20S proteasome and a potential competitor of the 19S (7 visite) (PDF 4 visite)
Cellular And Molecular Life Sciences (ISSN: 1420-9071electronic, 1420-682xlinking), 2018 Sep; 75(18): 3441-3456.
Impact Factor: 7.047
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mercurio FA, Di Natale C, Pirone L, Iannitti R, Marasco D, Pedone EM, Palumbo R, Leone M
* The Sam-Sam interaction between Ship2 and the EphA2 receptor: design and analysis of peptide inhibitors (66 visite)
Sci Rep (ISSN: 2045-2322electronic, 2045-2322linking), 2017 Dec 12; 7(1): 17474-17474.
Impact Factor: 4.259
Dettagli    Esporta in BibTeX    Esporta in EndNote

Dato AD, Cunsolo A, Persico M, Santoro AM, D'Urso A, Milardi D, Purrello R, Stefanelli M, Paolesse R, Tundo GR, Sbardella D, Fattorusso C, Coletta M
* Electrostatic Map Of Proteasome alpha-Rings Encodes The Design of Allosteric Porphyrin-Based Inhibitors Able To Affect 20S Conformation By Cooperative Binding (61 visite)
Sci Rep (ISSN: 2045-2322electronic, 2045-2322linking), 2017 Dec 6; 7(1): 17098-17098.
Impact Factor: 5.078
Dettagli    Esporta in BibTeX    Esporta in EndNote

Oliveri V, Lanza V, Milardi D, Viale M, Maric I, Sgarlata C, Vecchio G
* Amino- and chloro-8-hydroxyquinolines and their copper complexes as proteasome inhibitors and antiproliferative agents (53 visite)
Metallomics (ISSN: 1756-591xelectronic, 1756-5901linking), 2017 Oct 18; 9(10): 1439-1446.
Impact Factor: 4.099
Dettagli    Esporta in BibTeX    Esporta in EndNote

Tomasello MF, Nardon C, Lanza V, Di Natale G, Pettenuzzo N, Salmaso S, Milardi D, Caliceti P, Pappalardo G, Fregona D
* New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway (98 visite)
Eur J Med Chem (ISSN: 1768-3254electronic, 0223-5234linking), 2017 Jun 19; 138: 115-127.
Impact Factor: 4.519
Dettagli    Esporta in BibTeX    Esporta in EndNote

Palmieri G, Cocca E, Gogliettino M, Valentino R, Ruvo M, Cristofano G, Angiolillo A, Balestrieri M, Rossi M, Di Costanzo A
* Low Erythrocyte Levels of Proteasome and Acyl-Peptide Hydrolase (APEH) Activities in Alzheimer's Disease: A Sign of Defective Proteostasis? (64 visite)
J Alzheimers Dis (ISSN: 1875-8908electronic, 1387-2877linking), 2017; 60(3): 1097-1106.
Impact Factor: 3.731
Dettagli    Esporta in BibTeX    Esporta in EndNote

Santoro AM, Monaco I, Attanasio F, Lanza V, Pappalardo G, Tomasello MF, Cunsolo A, Rizzarelli E, De Luigi A, Salmona M, Milardi D
* Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study (99 visite)
Sci Rep (ISSN: 2045-2322electronic, 2045-2322linking), 2016 Sep 16; 6: 33444-33444.
Impact Factor: 4.259
Dettagli    Esporta in BibTeX    Esporta in EndNote

Santoro AM, Cunsolo A, D'Urso A, Sbardella D, Tundo GR, Ciaccio C, Coletta M, Diana D, Fattorusso R, Persico M, Di Dato A, Fattorusso C, Milardi D, Purrello R
* Cationic porphyrins are tunable gatekeepers of the 20S proteasome (470 visite) (PDF 142 visite)
Chemical Science (ISSN: 2041-6539, 2041-6520), 2016; 7(2): 1286-1297.
Impact Factor: 8.668
Dettagli    Esporta in BibTeX    Esporta in EndNote

Carriero MV, Bifulco K, Minopoli M, Lista L, Maglio O, Mele L, Di Carluccio G, De Rosa M, Pavone V
* UPARANT: a urokinase receptor-derived peptide inhibitor of VEGF-driven angiogenesis with enhanced stability and in vitro and in vivo potency (134 visite)
Mol Cancer Ther Molecular Cancer Therapeutics (ISSN: 1538-8514electronic, 1535-7163linking), 2014 May; 13(5): 1092-1104.
Impact Factor: 5.683
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ciccarelli M, Rusciano MR, Sorriento D, Basilicata MF, Santulli G, Campiglia P, Bertamino A, De Luca N, Trimarco B, Iaccarino G, Illario M
* CaMKII protects MKP-1 from proteasome degradation in endothelial cells (78 visite)
Cell Signal Cellular Signalling (ISSN: 0898-6568), 2014; 26(10): 2167-2174.
Impact Factor: 4.315
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bergamo P, Cocca E, Palumbo R, Gogliettino M, Rossi M, Palmieri G
* RedOx status, proteasome and APEH: Insights into anticancer mechanisms of t10, c12-conjugated linoleic acid isomer on A375 melanoma cells (141 visite)
Plos One (ISSN: 1932-6203, 1932-6203electronic), 2013 Nov 19; 8(11): N/D-N/D.
Impact Factor: 3.534
Dettagli    Esporta in BibTeX    Esporta in EndNote

Galdiero S, Falanga A, Tarallo R, Russo L, Galdiero E, Cantisani M, Morelli G, Galdiero M
* Peptide inhibitors against herpes simplex virus infections (139 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2013 Mar; 19(3): 148-158.
Impact Factor: 1.862
Dettagli    Esporta in BibTeX    Esporta in EndNote

Santoro AM, Lo Giudice MC, D'Urso A, Lauceri R, Purrello R, Milardi D
* Cationic porphyrins are reversible proteasome inhibitors (150 visite)
J Am Chem Soc (ISSN: 0002-7863, 0002-2786, 1520-5126), 2012 Jun 27; 134(25): 10451-10457.
Impact Factor: 10.677
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sandomenico A, Russo A, Palmieri G, Bergamo P, Gogliettino M, Falcigno L, Ruvo M
* Small peptide inhibitors of acetyl-peptide hydrolase having an uncommon mechanism of inhibition and a stable bent conformation (117 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2012 Mar 8; 55(5): 2102-2111.
Impact Factor: 5.614
Dettagli    Esporta in BibTeX    Esporta in EndNote



14 Records (13 escludendo Abstract e Conferenze).
Impact factor totale: 73.345 (69.811 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 73.837 (69.822 escludendo Abstract e Conferenze).







    Esporta in BibTeX    Esporta in EndNote

Ultima modifica di Gennaro Angrisano in data Thursday 06 October 2016, 18:01:04
91 visite. Ultima visita in data Tuesday 11 December 2018, 2:58:44

Webmaster and developer: Marco Comerci
Per problemi e suggerimenti: adminibb.cnr.it
Ultimo aggiornamento: Monday 17 December 2018, 14:29:05